Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

PPL Therapeutics

PPL Therapeutics is said to be planning to shed at least 90 jobs at its research facility in Roslin, after partner Bayer stopped a project to develop treatments for lung disorders.

PPL Therapeutics has dropped plans to build a £42m biotechnology plant near Edinburgh, and may now outsource its manufacturing operations.

PPL Therapeutics is to sell its xenograft and stem cell activities to a newly-formed US company called Regenecor Holdings, in which PPL will hold an equity stake.

PPL Therapeutics is looking to raise about £20m in a share issue to fund the development of its new drug manufacturing facilities.

PPL Therapeutics has confirmed plans to build a £42m bio-manufacturing facility at the Gowkley Moss Farm site near Penicuik, Midlothian, where it will employ up to 250 people.

PPL Therapeutics has announced plans to build a £42m drug manufacturing plant in Scotland with the creation of 150 jobs, and is seeking a suitable site in the Lothians.